201 related articles for article (PubMed ID: 15132046)
1. What's new in the fight against AIDS.
Godwin C
RN; 2004 Apr; 67(4):46-52; quiz 53. PubMed ID: 15132046
[No Abstract] [Full Text] [Related]
2. New antiretroviral agents and the complexity of treatment practices.
Smith D
J HIV Ther; 2008 Jun; 13(2):25-6. PubMed ID: 18953270
[No Abstract] [Full Text] [Related]
3. [HIV-infection].
Wasmuth JC; Rockstroh JK
Dtsch Med Wochenschr; 2007 Mar; 132(13):673-83; quiz 685-6. PubMed ID: 17377882
[No Abstract] [Full Text] [Related]
4. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral therapy in HIV.
Yu A; Berbari E; Temesgen Z
J Med Liban; 2006; 54(2):74-9. PubMed ID: 17086997
[TBL] [Abstract][Full Text] [Related]
6. Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs.
Lundgren JD; Phillips AN
BMJ; 2004 Jan; 328(7434):253. PubMed ID: 14751897
[No Abstract] [Full Text] [Related]
7. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
[TBL] [Abstract][Full Text] [Related]
8. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
Müller AD; Myer L; Jaspan H
Clin Infect Dis; 2009 Jan; 48(1):e3-5. PubMed ID: 19025495
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral therapy in the treatment-experienced patient.
Gallant JE
AIDS Read; 1999 Jul; 9(4):284-91. PubMed ID: 12737118
[TBL] [Abstract][Full Text] [Related]
10. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
Jones R; Gazzard B
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
[TBL] [Abstract][Full Text] [Related]
11. Survival time of AIDS patients in Bamrasnaradura Institute.
Chaovavanich A; Chottanapund S; Ausavapipit J; Adulyawat N; Ubonsai W
J Med Assoc Thai; 2006 Nov; 89(11):1859-63. PubMed ID: 17205866
[TBL] [Abstract][Full Text] [Related]
12. [Current AIDS drugs].
Praxis (Bern 1994); 1997 Feb; 86(9):364-5. PubMed ID: 9157508
[No Abstract] [Full Text] [Related]
13. Millions of life-years saved with potent antiretroviral drugs in the United States: a celebration, with challenges.
Vermund SH
J Infect Dis; 2006 Jul; 194(1):1-5. PubMed ID: 16741874
[No Abstract] [Full Text] [Related]
14. [Options in HIV therapy: present and future].
Röling J; Draenert R; Goebel FD
Internist (Berl); 2005 Aug; 46(8):892-4, 896-8. PubMed ID: 15968521
[TBL] [Abstract][Full Text] [Related]
15. Development of therapeutics for AIDS: structure-based molecular targeting.
Maeda K; Mitsuya H
Tuberculosis (Edinb); 2007 Aug; 87 Suppl 1():S31-4. PubMed ID: 17625972
[TBL] [Abstract][Full Text] [Related]
16. Designing anti-AIDS drugs targeting the major mechanism of HIV-1 RT resistance to nucleoside analog drugs.
Sarafianos SG; Hughes SH; Arnold E
Int J Biochem Cell Biol; 2004 Sep; 36(9):1706-15. PubMed ID: 15183339
[TBL] [Abstract][Full Text] [Related]
17. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.
Persaud D; Palumbo P; Ziemniak C; Chen J; Ray SC; Hughes M; Havens P; Purswani M; Gaur AH; Chadwick EG;
J Infect Dis; 2007 May; 195(10):1402-10. PubMed ID: 17436219
[TBL] [Abstract][Full Text] [Related]
18. [Research on the selective kinetics of HIV-1 nucleoside reverse transcriptase inhibitor drug resistance-associated mutations among 4 AIDS patients receiving highly active antiretroviral therapy].
Li J; Jiao LY; Li HP; Li L; Liu YJ; Zhuang DM; Liu SY; Bao ZY; Li H; Wang Z; Li JY
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Aug; 29(8):794-800. PubMed ID: 19103117
[TBL] [Abstract][Full Text] [Related]
19. HIV-1. Viral assembly inhibitors on the horizon.
Brazil M
Nat Rev Drug Discov; 2005 Sep; 4(9):716-7. PubMed ID: 16211702
[No Abstract] [Full Text] [Related]
20. The global status of resistance to antiretroviral drugs.
Vella S; Palmisano L
Clin Infect Dis; 2005 Aug; 41 Suppl 4():S239-46. PubMed ID: 16032559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
